ILA 3.61% 8.0¢ island pharmaceuticals limited

Ann: ISLA-101 Phase 2a clinical trial update, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,447 Posts.
    lightbulb Created with Sketch. 866
    What impresses me is the clinical trial quality and the fairly low cost.

    Only c.$1M AUD to complete Phase 2a when typical Phase 2 trials are 10x the cost to run.

    We will have a comprehensive understanding of the mode of action and Dengue efficacy late 2022. Sit and wait investment.
 
watchlist Created with Sketch. Add ILA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.